Now showing items 1-4 of 4

    • Naranjo, J.; Poniachik Teller, Jaime; Cisco, D.; Contreras Levicoy, Juan; Oksenberg Reisberg, Dan; Valera M., José Miguel; Díaz Jeraldo, Juan; Rojas, J.; Cardemil Herrera, Gonzalo; Mena, S.; Castillo, J.; Rencoret, Guillermo; Godoy, J.; Escobar Delgado, Jaime; Rodríguez, J.; Leyton, Patricio; Fica Cubillos, Alberto; Toledo, C. (2007)
      Oral ulcers are a frequent problem in transplant medicine. It is important to consider infectious etiologies, exacerbated by the immunosuppressive treatment, but other etiologies are also possible, like adverse drug ...
    • Salech Morales, Felipe; Valderrama, Sebastián; Nervi, Bruno; Oksenberg Reisberg, Dan; Rodríguez, Juan Carlos; Smok Sahid, Gladys; Koch, Alvaro; Duarte, Ignacio; Pérez Ayuso, Rosa María; Jarufe, Nicolás; Martínez, Jorge; Soza, Alejandro; Arrese, Marco; Riquelme, Arnoldo (MEXICAN ASSOC HEPATOLOGY, 2011-03)
      Hepatic epithelioid hemangioendothelioma (HEH) is an unusual, low-grade malignant vascular tumor of the liver. Here we describe a case of a 40-year-old woman who presented with abdominal pain in the upper right quadrant ...
    • Hepp, Juan; Zapata, Rodrigo; Buckel González, Erwin; Martínez, Jorge; Uribe Maturana, Mario; Díaz Jeraldo, Juan; Ferrario, Mario; Sanhueza, Edgar; Pérez, Rosa María; Hunter, Bessie; Ríos, Gloria; Humeres, Roberto; Poniachik Teller, Jaime; Oksenberg Reisberg, Dan; Arrese, Marco (SOC MEDICA SANTIAGO, 2008-06)
      Liver transplantation is an excellent therapeutic option for terminal liver disease, During the last decades the results of liver transplantation have improved significantly with a patient survival rate of nearly 90% at ...
    • Pizarro, Carolina; Contreras, Jorge; Castillo Koch, Jaime; Silva, Javier; Oksenberg Reisberg, Dan; Hurtado Heim, Carmen; Venegas Santos, Mauricio; Díaz Jeraldo, Juan; Cardemil Herrera, Gonzalo; Ibarra, José; Bórquez, Angélica; Poniachik Teller, Jaime (SOC MEDICA SANTIAGO, 2012-01)
      Infection recurrence rates among hepatitis B virus infected liver allograft recipients, may be as high as 80%. Immunoprophylaxis with anti HBV gammaglobulin may reduce these rates and improve survival. The dose of anti HBV ...